EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of Pleiotropic TrkB and 5-HT4 Receptor Ligands as Neuroprotective Agents

Mirjana Antonijevic, Despoina Charou, Audrey Davis iD, Thomas Curel iD, Maria Valcarcel, Isbaal Ramos iD, Patricia Villacé, Sylvie Claeysen iD, Patrick Dallemagne iD, Achille Gravanis iD, Ioannis Charalampopoulos iD, Christophe Rochais iD

Molecules · 2024

DOI: 10.3390/molecules29020515 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Mirjana Antonijevic und 11 weiteren Autor:innen. Beteiligte Einrichtung: Normandie University, Unicaen, Centre d'Etudes et de Recherche sur le Médicament de Normandie (CERMN), 14000 Caen, France. Hauptthemen laut MEDLINE: Neuroprotective Agents, Neurodegenerative Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission, European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One common event that is the most detrimental in neurodegenerative disorders, even though they have a complex pathogenesis, is the increased rate of neuronal death. Endogenous neurotrophins consist of the major neuroprotective factors, while brain-derived neurotrophic factor (BDNF) and its high-affinity tyrosine kinase receptor TrkB are described in a number of studies for their important neuronal effects. Normal function of this receptor is crucial for neuronal survival, differentiation, and synaptic function. However, studies have shown that besides direct activation, the TrkB receptor can be transactivated via GPCRs. It has been proven that activation of the 5-HT4 receptor and transactivation of the TrkB receptor have a positive influence on neuronal differentiation (total dendritic length, number of primary dendrites, and branching index). Because of that and based on the main structural characteristics of LM22A-4, a known activator of the TrkB receptor, and RS67333, a partial 5-HT4 receptor agonist, we have designed and synthesized a small data set of novel compounds with potential dual activities in order to not only prevent neuronal death, but also to induce neuronal differentiation in neurodegenerative disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroprotective AgentsNeurodegenerative DiseasesHumansReceptor, trkBSerotoninCells, CulturedBrain-Derived Neurotrophic Factor

Stichwörter der Autor:innen

5-HT4 receptorTrkB receptorneurite differentiationneurodegenerationneuronal survival

Substanzen

Receptor, trkBNeuroprotective AgentsSerotoninBrain-Derived Neurotrophic Factor

Autor:innen und Institutionen

  • Normandie University, Unicaen, Centre d'Etudes et de Recherche sur le Médicament de Normandie (CERMN), 14000 Caen, France.
  • Department of Pharmacology, Medical School, University of Crete, 70013 Heraklion, Greece.
  • Institute of Molecular Biology & Biotechnology, Foundation of Research & Technology-Hellas, 70013 Heraklion, Greece.
  • IGF, Univ Montpellier, CNRS, INSERM, 34000 Montpellier, France.
  • Innoprot S.L, 48160 Derio, Spain.

ORCID-Profile: Audrey Davis, Thomas Curel, Isbaal Ramos, Sylvie Claeysen, Patrick Dallemagne, Achille Gravanis, Ioannis Charalampopoulos, Christophe Rochais

Förderung

  • European Commission
  • European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant

Zitieren

APA

Antonijevic, M., Charou, D., Davis, A., Curel, T., Valcarcel, M., Ramos, I., Villacé, P., Claeysen, S., Dallemagne, P., Gravanis, A., Charalampopoulos, I., & Rochais, C. (2024). Development of Pleiotropic TrkB and 5-HT4 Receptor Ligands as Neuroprotective Agents. Molecules. https://doi.org/10.3390/molecules29020515

Vancouver

Antonijevic M, Charou D, Davis A, Curel T, Valcarcel M, Ramos I, et al. Development of Pleiotropic TrkB and 5-HT4 Receptor Ligands as Neuroprotective Agents. Molecules. 2024. doi:10.3390/molecules29020515

BibTeX
@article{Antonijevic2024,
  author = {Antonijevic, Mirjana and Charou, Despoina and Davis, Audrey and Curel, Thomas and Valcarcel, Maria and Ramos, Isbaal and Villacé, Patricia and Claeysen, Sylvie and Dallemagne, Patrick and Gravanis, Achille and Charalampopoulos, Ioannis and Rochais, Christophe},
  title = {Development of Pleiotropic TrkB and 5-HT4 Receptor Ligands as Neuroprotective Agents},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29020515}
}
Kostenlos starten →